awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33397131-30127D5D-88A5-40E8-84CD-AA1101F3AE42
Q33397131-30127D5D-88A5-40E8-84CD-AA1101F3AE42
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33397131-30127D5D-88A5-40E8-84CD-AA1101F3AE42
A phase I-II study of elacytarabine (CP-4055) in the treatment of patients with ovarian cancer resistant or refractory to platinum therapy.
P6179
Q33397131-30127D5D-88A5-40E8-84CD-AA1101F3AE42
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33397131-30127D5D-88A5-40E8-84CD-AA1101F3AE42
rank
NormalRank
type
BestRank
Statement
P6179
1012255910
http://www.w3.org/2001/XMLSchema#string